LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $255,000 | -31.8% | 39,612 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $374,000 | -76.5% | 39,612 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,594,000 | +46.2% | 79,224 | +112.0% | 0.00% | 0.0% |
| Q2 2018 | $1,090,000 | +15.3% | 37,363 | +17.8% | 0.00% | 0.0% |
| Q1 2018 | $945,000 | -7.4% | 31,722 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,021,000 | -4.8% | 31,722 | +2.8% | 0.00% | 0.0% |
| Q3 2017 | $1,073,000 | +16.8% | 30,859 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $919,000 | +21.2% | 30,859 | +21.5% | 0.00% | 0.0% |
| Q1 2017 | $758,000 | +70.3% | 25,390 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $445,000 | -17.3% | 25,390 | +12.4% | 0.00% | 0.0% |
| Q3 2016 | $538,000 | +45.8% | 22,599 | -1.9% | 0.00% | 0.0% |
| Q2 2016 | $369,000 | -23.3% | 23,042 | +0.2% | 0.00% | 0.0% |
| Q1 2016 | $481,000 | -22.5% | 22,986 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $621,000 | +33.0% | 22,986 | +36.7% | 0.00% | 0.0% |
| Q3 2015 | $467,000 | +13.3% | 16,817 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $412,000 | – | 16,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |